Kaleido Biosciences Inc (KLDO)

NASDAQ
2.010
-0.150(-6.94%)
  • Volume:
    107,441
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.900 - 2.180

KLDO Overview

Prev. Close
2.16
Day's Range
1.9-2.18
Revenue
850K
Open
2.09
52 wk Range
1.9-20.5
EPS
-2.24
Volume
107,441
Market Cap
83.06M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
141,856
P/E Ratio
-
Beta
-
1-Year Change
-82.66%
Shares Outstanding
42,594,350
Next Earnings Date
Mar 07, 2022
What is your sentiment on Kaleido Biosciences Inc?
or
Vote to see community's results!

Kaleido Biosciences Inc Company Profile

Employees
82

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. It also has a strategic collaboration with the COPD Foundation to study KB109 in patients with chronic obstructive pulmonary disease. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsStrong BuySellStrong SellStrong SellStrong Sell
SummaryBuySellStrong SellStrong SellStrong Sell
  • https://www.reddit.com/r/MicrocapStocksRun/comments/p105qc/4_biotech_stocks_for_your_investment_watchlist/?utm_source=share&utm_medium=web2x&context=3
    0
    • Scam! No future!
      0
      • hello anybody who can help me about Kaleido ? the price will rise up or not please ?
        0
        • poor financial reports
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.